Imidazoacridine Compounds for Treating FLT3-Mediated Disorders

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20100016300A1
SERIAL NO

12375997

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method of treating a FLT3-mediated condition in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt thereof: (I), The conditions that can be treated by the compounds of the present invention and the definitions for the variables in formula (I) are provided herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XANTHUS PHARMACEUTICALS INC300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ajami, Alfred M Brookline, US 15 124

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation